Results 191 to 200 of about 14,112 (260)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Building a single market for data: Data spaces as pro-competitive infrastructure. [PDF]

Data Brief
Konstantopoulou ES.
europepmc   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad, Anshu Arora, Arun Arora, Jeena Vaid, Arif Khan   +4 more
wiley   +1 more source

Call for a ban on gender-centric verbal violence through women-centric offensive abuses elicited in the names of mothers, sisters & daughters in the mass media and public spaces. [PDF]

J Family Med Prim Care
Kumar R.
europepmc   +1 more source

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source

Predicting Pediatric Sepsis Outcomes: A Comparison of 3 Sepsis Risk Scores in Bangladesh. [PDF]

Sage Open Pediatr
Kadakia N, Amanullah S, Gjelsvik A, Mamun GMS, Shaima SN, Gainey M, Rahman ASMMH, Genisca A, Jindal A, Sarmin M, Afroze F, Shin J, Faruk MT, Shahid ASMSB, Ahmed T, Chisti MJ, Levine AC, Garbern SC.   +17 more
europepmc   +1 more source

Arguments and Analogies: Do Children Have a Right to Know Their Genetic Origins? [PDF]

Hastings Cent Rep
Charles S.
europepmc   +1 more source

Medicolegal Aspects of Neurosurgery in India: A Narrative Review. [PDF]

Cureus
Sathia Prabhu A, Rakshit P, Patra AP, Vilanilam G, Yadav V.   +4 more
europepmc   +1 more source

Strengthening the TB response with artificial intelligence and the right to health. [PDF]

IJTLD Open
Citro B, Zaidi S, Malar J, Klymenko O, Hermawan B.   +4 more
europepmc   +1 more source

Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms

British Journal of Clinical Pharmacology, EarlyView.
Domenico Nocera, Giusi Forastiero, Andrea Logreco, Alessia Proietti, Antonio Galluccio, Carlotta Lunghi, Elisabetta Poluzzi, Fabrizio De Ponti   +7 more
wiley   +1 more source